Ifresh Inc (IFMK) Fundamental Analysis & Valuation

NASDAQ:IFMK

Current stock price

0.4901
-0.67 (-57.75%)
At close:
0.46
-0.03 (-6.14%)
After Hours:

This IFMK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IFMK Profitability Analysis

1.1 Basic Checks

  • IFMK had negative earnings in the past year.
IFMK Yearly Net Income VS EBIT VS OCF VS FCFIFMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 5M -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA 0.57%
ROE 3.62%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IFMK Yearly ROA, ROE, ROICIFMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 200 400 600 800 1K

1.3 Margins

Industry RankSector Rank
OM -2.97%
PM (TTM) 0.8%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IFMK Yearly Profit, Operating, Gross MarginsIFMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. IFMK Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, IFMK has more shares outstanding
  • The debt/assets ratio for IFMK has been reduced compared to a year ago.
IFMK Yearly Shares OutstandingIFMK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 5M 10M 15M
IFMK Yearly Total Debt VS Total AssetsIFMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 20M 40M 60M 80M

2.2 Solvency

  • IFMK has an Altman-Z score of 0.44. This is a bad value and indicates that IFMK is not financially healthy and even has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.01 indicates that IFMK is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.44
ROIC/WACCN/A
WACCN/A
IFMK Yearly LT Debt VS Equity VS FCFIFMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 5M -5M 10M -10M

2.3 Liquidity

  • IFMK has a Current Ratio of 0.64. This is a bad value and indicates that IFMK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.38 indicates that IFMK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.38
IFMK Yearly Current Assets VS Current LiabilitesIFMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. IFMK Growth Analysis

3.1 Past

  • IFMK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.89%, which is quite impressive.
  • Looking at the last year, IFMK shows a decrease in Revenue. The Revenue has decreased by -5.11% in the last year.
  • Measured over the past years, IFMK shows a decrease in Revenue. The Revenue has been decreasing by -6.89% on average per year.
EPS 1Y (TTM)96.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.36%
Revenue 1Y (TTM)-5.11%
Revenue growth 3Y-11.9%
Revenue growth 5Y-6.89%
Sales Q2Q%22.69%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IFMK Yearly Revenue VS EstimatesIFMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M

More info and screens

Find the best growth stocksShow best growing peers

0

4. IFMK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IFMK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IFMK Price Earnings VS Forward Price EarningsIFMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 86.62
IFMK Per share dataIFMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IFMK Dividend Analysis

5.1 Amount

  • IFMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

IFMK Fundamentals: All Metrics, Ratios and Statistics

Ifresh Inc

NASDAQ:IFMK (11/22/2021, 8:15:34 PM)

After market: 0.46 -0.03 (-6.14%)

0.4901

-0.67 (-57.75%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.21%
Inst Owner Change-1.59%
Ins Owners30.11%
Ins Owner Change0%
Market Cap22.15M
Revenue(TTM)94.25M
Net Income(TTM)750.00K
Analysts0
Price TargetN/A
Short Float %0.02%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB N/A
EV/EBITDA 86.62
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.09
BVpS0.46
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 3.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -2.97%
PM (TTM) 0.8%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.38
Altman-Z 0.44
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.11%
Revenue growth 3Y-11.9%
Revenue growth 5Y-6.89%
Sales Q2Q%22.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Ifresh Inc / IFMK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Ifresh Inc?

ChartMill assigns a fundamental rating of 2 / 10 to IFMK.


What is the valuation status of Ifresh Inc (IFMK) stock?

ChartMill assigns a valuation rating of 2 / 10 to Ifresh Inc (IFMK). This can be considered as Overvalued.


What is the profitability of IFMK stock?

Ifresh Inc (IFMK) has a profitability rating of 2 / 10.


How financially healthy is Ifresh Inc?

The financial health rating of Ifresh Inc (IFMK) is 2 / 10.